 antibodi coxsacki viru postvir fatigu syndrom object associ coxsacki viru infect postvir fatigu syndrom immunolog abnorm syndrom design case-control studi patient postvir fatigu syndrom local gener practition year set gener practition referr dunbartonshir scotland patient patient postvir fatigu syndrom exhaust myalgia symptom refer postvir fatigu syndrom recent onset sever month age sex control gener practition patient wrong diagnos resolut symptom refus patient match control main outcom measur questionnair patient control clinic examin patient blind analysi blood sampl entri month determin coxsacki viru igm igg antibodi variabl lymphocyt protein synthesi lymphocyt subset immun complex result percentag posit rate coxsacki viru igm entri patient control coxsacki viru igg signific differ differ categori patient clinic likelihood syndrom predict valu fourfold rise fall coxsacki viru igg titr patient entri review month rate posit antibodi test result patient control strong season variat numer immunolog test detect signific abnorm particular mean valu immun complex concentr much patient control normal rang mean valu total igm patient control normal rang conclus serolog test avail coxsacki viru antibodi postvir fatigu syndrom posit rate antibodi patient background popul rais concentr total igm immun complex